Perhaps.....
Great question--here's where there is an urgent need for US Govt sponsored research--perhaps headed up by NIDA? We simply do not know, sadly.
https://doi.org/10.1016/j.phrs.2025.108080 how exactly is that with that "all psychedelics are 5ht2b agonists" ?
Not what we find https://www.sciencedirect.com/science/article/abs/pii/S0896627325004702
I think I was the first to bring C6 into the lab a few years before the caveolin paper ;)
https://doi.org/10.1016/S0026-895X(24)12511-4
Might wanna start preloading - https://pubmed.ncbi.nlm.nih.gov/40497800/
Do you have any ideas about safe lifetime limits for MDMA? The Droogmans paper has such high error bars that I'm not sure what to make from the results.
I'm trying to include some safety recommendations in my MDMA therapy manual: https://osf.io/preprints/psyarxiv/aps5g
Great question--here's where there is an urgent need for US Govt sponsored research--perhaps headed up by NIDA? We simply do not know, sadly.
https://doi.org/10.1016/j.phrs.2025.108080 how exactly is that with that "all psychedelics are 5ht2b agonists" ?
Not what we find https://www.sciencedirect.com/science/article/abs/pii/S0896627325004702
I think I was the first to bring C6 into the lab a few years before the caveolin paper ;)
https://doi.org/10.1016/S0026-895X(24)12511-4
Might wanna start preloading - https://pubmed.ncbi.nlm.nih.gov/40497800/
Do you have any ideas about safe lifetime limits for MDMA? The Droogmans paper has such high error bars that I'm not sure what to make from the results.
I'm trying to include some safety recommendations in my MDMA therapy manual: https://osf.io/preprints/psyarxiv/aps5g